Human amniotic epithelial cells express melatonin receptor MT1, but not melatonin receptor MT2: A new perspective to neuroprotection

Journal of Pineal Research

Volumn 50, Issue 3, 2011, Pages 272-280

  Kaneko, Yuji ^a   Hayashi, Takuro ^a   Yu, SeongJin ^a   Tajiri, Naoki ^a   Bae, Eunkyung C ^a   Solomita, Marianna A ^a   Chheda, Sonia H ^a   Weinbren, Nathan L ^a   Parolini, Ornella ^b   Borlongan, Cesar V ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b Fondazione Poliambulanza Istituto Ospedaliero   (Italy)

Author keywords

Oxidative stress; Receptor ligand technology; Stem cells; Stroke; Trophic factors

Indexed keywords

HYDROGEN PEROXIDE; MELATONIN; MELATONIN 1 RECEPTOR; MELATONIN 2 RECEPTOR; VASCULOTROPIN;

AMNION; ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DOSE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; NERVE CELL DIFFERENTIATION; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PHASE CONTRAST MICROSCOPY; RAT; STEM CELL; STROKE;

AMNION; ANTIOXIDANTS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITHELIAL CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; MELATONIN; OXIDATIVE STRESS; RECEPTOR, MELATONIN, MT1; RECEPTOR, MELATONIN, MT2;

EID: 79952572941     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/j.1600-079X.2010.00837.x     Document Type: Article

References (43)

1. Antonucci I, Iezzi I, Morizio E et al. Isolation of osteogenic progenitors from human amniotic fluid using a single step culture protocol. BMC Biotechnol 2009; 9:9.
2. Miki T, Marongiu F, Dorko K et al. Isolation of amniotic epithelial stem cells. Curr Protoc Stem Cell Biol 2010; Chapter 1: Unit 1E.3.
3. Antonucci I, Pantalone A, De Amicis D et al. Human amniotic fluid stem cells culture onto titanium screws: a new perspective for bone engineering. J Biol Regul Homeost Agents 2009; 23:277-279.
4. Cargnoni A, Di Marcello M, Campagnol M et al. Amniotic membrane patching promotes ischemic rat heart repair. Cell Transplant 2009; 18:1147-1149.
5. Yu SJ, Soncini M, Kaneko Y et al. Amnion: a potent graft source for cell therapy in stroke. Cell Transplant 2009; 18:111-118.
6. Manuelpillai U, Tchongue J, Lourensz D et al. Transplantation of Human Amnion Epithelial Cells Reduces Hepatic Fibrosis in Immunocompetent CCl Treated Mice. Cell Transplant 2010; in press.
7. Shinya M, Komuro H, Saihara R et al. Neural differentiation potential of rat amniotic epithelial cells. Fetal Pediatr Pathol 2010; 29:133-143.
8. Reiter RJ, Tan DX, Leon J et al. When melatonin gets on your nerves: its beneficial actions in experimental models of stroke. Exp Biol Med 2005; 230:104-117.
9. Reiter RJ, Tan DX, Manchester LC, Tamura H. Melatonin defeats neurally-derived free radicals and reduces the associated neuromorphological and neurobehavioral damage. J Physiol Pharmacol 2007; 58:5-22.
10. Killic E, Killic U, Reiter RJ et al. Prophylactic use of melatonin protects against focal cerebral ischemia in mice: role of endothelin converting enzyme-1. J Pineal Res 2004; 37:247-251. (Pubitemid 39457045)
11. Killic U, Killic E, Reiter RJ et al. Signal transduction pathways involved in melatonin-induced neuroprotection after focal cerebral ischemia in mice. J Pineal Res 2005; 38:67-71. (Pubitemid 40139312)
12. Killic E, Killic U, Bacigaluppi M et al. Delayed melatonin administration promotes neuronal survival, neurogenesis and motor recovery, and attenuates hyperactivity and anxiety after mild focal cerebral ischemia in mice. J Pineal Res 2008; 45:142-148.
13. Cermakian N, Bovin DB. The regulation of central and peripheral circadian clocks in humans. Obes Rev 2009; 10:25-36.
14. Shekleton JA, Parcell DL, Redman JR et al. Sleep disturbance and melatonin levels following traumatic brain injury. Neurology 2010; 74:1732-1738.
15. Borlongan CV, Yamamoto M, Takei N et al. Glial cell survival is enhanced during melatonin-induced neuroprotection against cerebral ischemia. FASEB J 2000; 14:1307-1317. (Pubitemid 30439739)
16. Koh PO. Melatonin regulates nitric oxide synthase expression in ischemic brain injury. J Vet Med Sci 2008; 70:747-750.
17. Lee CH, Yoo KY, Choi JH et al. Melatonin's protective action against ischemic neuronal damage is associated with up-regulation of the MT2 melatonin receptor. J Neurosci Res 2010; 88:2630-2640.
18. Lekic T, Hartman R, Tojas H et al. Protective effect of melatonin upon neuropathology, striatal function, and memory ability after intracerebral hemorrhage in rats. J Neurotrauma 2010; 27:627-637.
19. Lin HW, Lee EJ. Effects of melatonin in experimental stroke models in acute, sub-acute, and chronic stages. Neurophsychiatr Dis Treat 2009; 5:157-162.
20. Tocharus J, Khonthun C, Chongthammakun S et al. Melatonin attenuates methamphetamine-induced overexpression of pro-inflammatory cytokines in microglial cell lines. J Pineal Res 2010; 48:347-352.
21. Beni SM, Kohen R, Reiter RJ et al. Melatonin induced neuroprotection after closed head injury is associated with increased brain antioxidants and attenuated late-phase activation of NF-kappaB and AP-1. FASEB J 2004; 18:149-151.
22. Ramirez-Rodriguez G, Klempin F, Babu H et al. Melatonin modulates cell survival of new neurons in the hippocampus of adult mice. Neuropsychopharmacology 2009; 34:2180-2191.
23. Wang X, Figueroa BE, Stavrovskaya IG et al. Methazolamide and melatonin inhibit mitochondrial cytochrome C release and are neuroprotective in experimental models of ischemic injury. Stroke 2009; 40:1877-1885.
24. Xu SC, He MD, Zhong M et al. Melatonin protects against nickel-induced neurotoxicity in vitro by reducing oxidative stress and maintaining mitochondrial function. J Pineal Res 2010; 49:86-94.
25. Reiter RJ, Paredes SD, Manchester LC et al. Reducing oxidative/ nitrosative stress: a newly-discovered genre for melatonin. Crit Rev Biochem Mol Biol 2009; 44:175-200.
26. Hudiger H, Tan DX, Reiter RJ. Kynuramines, metabolites of melatonin and other indoles: the resurrection of an almost forgotten class of biogenic amines. J Pineal Res 2009; 47:109-126.
27. Samantaray S, Das A, Thakore N et al. Therapeutic potential of melatonin in traumatic central nervous system injury. J Pineal Res 2009; 47:134-142.
28. Moriya T, Horie H, Mitome M et al. Melatonin influences the proliferative and differentiative activity of neural stem cells. J Pineal Res 2007; 42:411-418. (Pubitemid 46581666)
29. Rennie K, De Butte M, Pappas BA. Melatonin promotes neurogenesis in dentate gyrus in the pinealectomized rat. J Pineal Res 2009; 47:313-317.
30. Borlngan CV, Sumaya I, Moss D et al. Melatonin-secreting pineal gland: a novel tissue source for neural transplantation therapy in stroke. Cell Transplant 2003; 12:225-234. (Pubitemid 36577000)
31. Sharma R, Mcmillan CR, Niles LP. Neural stem cell transplantation and melatonin treatment in a 6-hydroxydopamine model of Parkinson's disease. J Pineal Res 2007; 43:245-254. (Pubitemid 47353003)
32. Niles LP, Armstrong KJ, Rincon Castro LM et al. Neural stem cells express melatonin receptors and neurotrophic factors: colocalization of the MT1 receptor with neuronal and glial markers. BMC Neurosci 2004; 5:41.
33. Chen HY, Hung YC, Chen TY et al. Melatonin improves presynaptic protein, SNAP-25, expression and dendritic spine density and enhances functional and electrophysiological recovery following transient focal cerebral ischemia in rats. J Pineal Res 2009; 47:260-270.
34. Das A, Mcdowell M, Pava MJ et al. The inhibition of apoptosis by melatonin in VSC4.1 motoneurons exposed to oxidative stress, glutamate excitotoxicity, or TNF-alpha toxicity involves membrane melatonin receptors. J Pineal Res 2010; 48:157-169.
35. Imbesi M, Uz T, Manev H. Role of melatonin receptors in the effects of melatonin on BDNF and neuroprotection in mouse cerebellar neurons. J Neural Transm 2008; 115:1495-1499.
36. Kong X, Li X, Cal Z et al. Melatonin regulates the viability and differentiation of rat midbrain neural stem cells. Cell Mol Neurobiol 2008; 28:569-579. (Pubitemid 351624509)
37. Tyagi E, Agrawal R, Nath C, Shukla R. Effect of melatonin on neuroinflammation and acetylcholinesterase activity induced by LPS in rat brain. Eur J Pharmacol 2010; 640:206-210.
38. Bertoldi S, Fare S, Denegri M et al. Ability of polyurethane foams to support placenta-derived cell adhesion and osteogenic differentiation: preliminary results. J Mater Sci Mater Med 2010; 21:1005-1011.
39. Wang X. The antiapoptotic activity of melatonin in neurodegenerative diseases. CNS Neurosci Ther 2009; 15:345-357.
40. Romeu LR, Da Motta EL, Maganhin CC et al. Effects of melatonin on histomorphology and on the expression of steroid receptors, VEGF, and PCNA in ovaries of pinealectomized female rats. Fertil Steril 2010; in press.
41. Hill SM, Cheng C, Yuan L et al. Declining melatonin levels and MT1 receptors expression in aging rats is associated with enhanced mammary tumor growth and decreased sensitivity to melatonin. Breast Cancer Res Treat 2010; in press.
42. Mao L, Cheng Q, Guardiola-Lemaitre B et al. In vitro and in vivo antitumor activity of melatonin receptor agonists. J Pineal Res 2010; 49:216-221.
43. Mor M, Rivara S, Pala D et al. Recent advances in the development of melatonin MT(1) and MT(2) receptor agonists. Expert Opin Ther Pat 2010; 20:1059-1077.